Table 2.
Species | Antigen(s) | Isotype | Disorder | Protection | References |
---|---|---|---|---|---|
Human, mice | Various self-antigens and neo-epitopes | IgM and IgG | Various: anti-inflammation, OxLDL, tumors, neurologic diseases, infections, clearance senescent cells and cytokines, passive protection to autoimmunity and tissue injury | Yes | (116) |
Pig | Chondroitin sulfate, | IgM, IgG | Osteochondrosis | Yes? | (99) |
Actin, KLH | |||||
Thyroglobulin | |||||
Mice | Myelin sulfatide | IgM | Multiple sclerosis | Yes | (101) |
Human | Amyloid | IgM | Alzheimer | Yes | (109–111) |
mice | Amyloid beta-peptide | Polyclonal | Alzheimer | Yes | (19) |
Human | Platelets | IgG | Schizophrenia | Yes | (117) |
Human | Malondialdehyde | IgM | Schizophrenia | Yes | (118) |
Pig | Myelin basic protein | IgM | unknown | (119) | |
Chicken | PC-BSA | IgM | Non-aggressive behavior | (120) | |
Chicken | PC-BSA | IgG | Aggressive behavior | (120) | |
Human | oxLDL | IgM | Carotid atherosclerosis | Yes | (121) |
Human | PC-KLH, PC-BSA | IgG | Cardiovascular diseases | Yes | (122, 123) |
Human | Phosphorylcholine, | IgM | Atherosclerosis, | Yes | (27, 124) |
Cardiolipin | Stroke, | ||||
Myocardial infections | |||||
Mice | Malondialdehyde | IgM | Hepatic inflammation | Yes | (125) |
Mice | Phosphoryl-enriched- | Not specified | Non-alcoholic | Yes | (126) |
Pneumococci | Steatohepatitis | ||||
Mice | Oxidized phospholipids | IgM | Atherosclerosis | Yes | (127) |
Mice | Phosphorylcholine, T15-idiotype | IgM | Vein graft atherosclerosis | Yes | (128) |
Chicken | KLH | IgM | longevity | (129, 130) | |
Cow | KLH | IgM, IgG | Mastitis | Unknown | (131) |
Human | Low density lipoprotein | IgM | Atherosclerosis | Yes | (132) |
IgG | Pro-atherosclerosis | ||||
Mice | CNS-cells | IgM | Remyelination | (101) | |
Mice | Gangliosides | IgM | Amyotrophic | (108) | |
Lateral sclerosis | |||||
Human | Galα1-3Galβ1-GlcNAc | IgM, IgG, | Henoch-Schönlein purpura | (43, 44, 54, 133) | |
IgA | IgA nephropathy | ||||
Crohn's disease |